Featured News

The Celiac Disease Foundation is expanding its operations with the appointment of three senior-level staff. These roles are aligned with the Foundation’s latest strategic plan and ongoing work to accelerate diagnosis, treatments, and a cure for celiac disease – one of the world’s most prevalent genetic autoimmune diseases.

On behalf of the entire celiac disease patient community, thank you for your participation in the Celiac Disease Foundation’s 2023 Gift of Hope campaign! Our annual year-end initiative to raise awareness and funds for celiac disease research was extraordinary – all thanks to YOU.

This month's story comes from Dan Gibbons, a patient advocate who also happens to be the Foundation's newest board member!

The Celiac Disease Foundation, a global leader in celiac disease patient advocacy, today announces its new relationship with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to provide resources for celiac disease patients and all consumers concerned about potential gluten in the company’s medications. 

The Celiac Disease Foundation and Celiac Cruise are pleased to announce an innovative partnership to offer safe and delicious gluten-free travel experiences, provide educational opportunities, and foster philanthropy within the celiac disease community.

The SynCeD Study is looking for adult volunteers with celiac disease to join a phase 2a clinical trial. Your participation could make a difference. 

Each November the Celiac Disease Foundation hosts our annual Turkey Trot to raise funds for celiac disease research to accelerate treatments and a cure. On November 11 and 12, more than 1,200 supporters from 38 states and countries around the world laced up to move 3.1 miles (5K) for a cure.

This month we hear from Sonia, the mother of a young celiac disease patient. Thank you, Sonia for sharing your family's story!

A recent international study co-authored by Celiac Disease Foundation grant award winner Dr. Benjamin Lebwohl aimed to assess the effectiveness of the Pfizer COVID-19 vaccine in patients with celiac disease. Results revealed that the Pfizer COVID-19 vaccine offers the same level of protection against the virus for patients with celiac disease as it does for those without the autoimmune disease.

This October the Celiac Disease Foundation hosted physicians and healthcare representatives from more than 15 hospitals for a gluten-free meal to celebrate researchers and officers of NASPGHAN’s Celiac Special Interest Group and the important work they do through their care for our patient community.